ArticleInternational journal of oncology2020

Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway.

Fengqi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.